title: [Cinobufagin treatment of relapsed or refractory hematological malignant tumor: 8 cases report and literatures review].
authors.affiliation: Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450000, China.
authors.forename: Lu
authors.initials: L
authors.lastname: Wang
authors.affiliation: Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450000, China.
authors.forename: Ruihua
authors.initials: R
authors.lastname: Mi
authors.affiliation: Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450000, China.
authors.forename: Xudong
authors.initials: X
authors.lastname: Wei
authors.affiliation: Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450000, China.
authors.forename: Lin
authors.initials: L
authors.lastname: Chen
authors.affiliation: Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450000, China.
authors.forename: Hao
authors.initials: H
authors.lastname: Ai
authors.affiliation: Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450000, China.
authors.forename: Qingsong
authors.initials: Q
authors.lastname: Yin
authors.affiliation: Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450000, China.
authors.forename: Ping
authors.initials: P
authors.lastname: Wang
mesh_terms: D002018:Bufanolides / Q000627:therapeutic use*; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D012008:Recurrence
chemical_list: D002018:Bufanolides; C002471:cinobufagin